Hotline:
+ 49 (0) 2204 2918806

Market studies for category Pharmaceuticals

Items 1 to 10 of 1683 total

  1. 1
  2. | 2
  3. | 3
  4. | 4
  5. | 5
  6. | 6
  7. | 7
  8. | 8
  9. | 9
  10. | 10
  11. ...
  12. | 169
  1. Net price*
    Year
  2. $9,995.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    PharmaPoint: Multiple Sclerosis - Global Drug Forecast and Market Analysis to 2022 Event-Driven Update

    GlobalData
    338 pages
    Multiple sclerosis (MS) is a chronic, inflammatory neurological disorder characterized pathologically by demyelination, axonal transection and neurodegeneration within the central nervous system. With curative therapy still elusive, current disease management is dependent on life-long pharmacotherapy with disease-modifying therapies (DMT)
    Englisch | Zukunftsanalyse | SKU: 401805
  3. $1,500.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    H. Lundbeck A/S – Product Pipeline Review – 2013

    Global Markets Direct
    167 pages
    Introduction Global Market Direct’s pharmaceuticals report, “H. Lundbeck A/S - Product Pipeline Review - 2013” provides data on the H. Lundbeck A/S’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. Th
    Englisch | Report | SKU: 329862
  4. $1,500.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    AmVac AG - Product Pipeline Review - 2013

    Global Markets Direct
    32 pages
    Global Market Direct’s pharmaceuticals report, “AmVac AG - Product Pipeline Review - 2013” provides data on the AmVac AG’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using da
    Englisch | Zukunftsanalyse | SKU: 386324
  5. $2,000.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Metastatic Prostate Cancer – Pipeline Review, H1 2013

    Global Markets Direct
    75 pages
    Introduction Global Markets Direct’s, 'Metastatic Prostate Cancer - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Metastatic Prostate Cancer, complete with latest updates, and special features on late-stage and discontinued
    Englisch | Report | SKU: 318790
  6. $495.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    ICT budget forecasts in Medium-sized Italian Educational Institutions - Estimated ICT budget breakdowns in 2013

    Kable Global ICT Intelligence
    19 pages
    SynopsisThis report illustrates how Kable expects Medium-sized Italian Educational Institutions to allocate their ICT budgets across the core areas of enterprise ICT spend, namely hardware, software, IT services, telecommunications and consulting.SummaryWhy was the report written?This report presents the output from Kable's ICT spend pred
    Englisch | Databook | SKU: 332327
  7. $2,000.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Cellulite – Pipeline Review, H1 2013

    Global Markets Direct
    44 pages
    Introduction Global Markets Direct’s, 'Cellulite - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Cellulite, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key play
    Englisch | Report | SKU: 329685
  8. $1,500.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Priaxon AG - Product Pipeline Review - 2013

    Global Markets Direct
    33 pages
    Global Market Direct’s pharmaceuticals report, “Priaxon AG - Product Pipeline Review - 2013” provides data on the Priaxon AG’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built usin
    Englisch | Zukunftsanalyse | SKU: 344544
  9. $3,495.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    N8-GP (Hemophilia A and B) - Forecast and Market Analysis to 2022

    GlobalData
    58 pages
    The competitive landscape of hemophilia A and B recombinant therapy in the US and 5EU is dominated by the use of recombinant FVIII and FIX replacement factors, and patients with severe forms of the disease receive frequent prophylactic infusions beginning from the first one or two years of life and often continuing through adulthood. Howe
    Englisch | Zukunftsanalyse | SKU: 387166
  10. $1,500.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    PharmaNeuroBoost NV - Product Pipeline Review - 2013

    Global Markets Direct
    29 pages
    Global Market Direct’s pharmaceuticals report, “PharmaNeuroBoost NV - Product Pipeline Review - 2013” provides data on the PharmaNeuroBoost NV’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This re
    Englisch | Zukunftsanalyse | SKU: 386388
  11. $2,000.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Relapsed Multiple Myeloma – Pipeline Review, H1 2013

    Global Markets Direct
    222 pages
    Introduction Global Markets Direct’s, 'Relapsed Multiple Myeloma - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Relapsed Multiple Myeloma, complete with latest updates, and special features on late-stage and discontinued pr
    Englisch | Report | SKU: 318854

Items 1 to 10 of 1683 total

  1. 1
  2. | 2
  3. | 3
  4. | 4
  5. | 5
  6. | 6
  7. | 7
  8. | 8
  9. | 9
  10. | 10
  11. ...
  12. | 169